Pharmacokinetics and pharmacodynamics of lixisenatide in patients with type 2 diabetes

Trial Profile

Pharmacokinetics and pharmacodynamics of lixisenatide in patients with type 2 diabetes

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Oct 2012

At a glance

  • Drugs Lixisenatide (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors Sanofi
  • Most Recent Events

    • 16 Oct 2012 Results from a subset of patients receiving once-daily lixisenatide investigating gastric emptying and the relationship to postprandial glycaemia have been reported as an abstract at EASD 2012.
    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top